183 related articles for article (PubMed ID: 32647988)
1. Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia.
Walker BS; Zarour LR; Wieghard N; Gallagher AC; Swain JR; Weinmann S; Lanciault C; Billingsley K; Tsikitis VL; Wong MH
World J Surg; 2020 Oct; 44(10):3501-3509. PubMed ID: 32647988
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
3. mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.
Chang JY; Kim JH; Kang J; Park Y; Park SJ; Cheon JH; Kim WH; Kim H; Park JJ; Kim TI
Yonsei Med J; 2020 Jul; 61(7):572-578. PubMed ID: 32608200
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract.
Levin TG; Powell AE; Davies PS; Silk AD; Dismuke AD; Anderson EC; Swain JR; Wong MH
Gastroenterology; 2010 Dec; 139(6):2072-2082.e5. PubMed ID: 20826154
[TBL] [Abstract][Full Text] [Related]
5. Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer.
Kalantari E; Taheri T; Fata S; Abolhasani M; Mehrazma M; Madjd Z; Asgari M
World J Surg Oncol; 2022 Jan; 20(1):15. PubMed ID: 35016698
[TBL] [Abstract][Full Text] [Related]
6. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
[TBL] [Abstract][Full Text] [Related]
7. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
9. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
Deng Y; Zhou J; Fang L; Cai Y; Ke J; Xie X; Huang Y; Huang M; Wang J
Br J Cancer; 2014 Jan; 110(2):430-4. PubMed ID: 24327017
[TBL] [Abstract][Full Text] [Related]
10. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
11. Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups.
Leavell BJ; Van Buren E; Antaki F; Axelrod BN; Rambus MA; Majumdar AP
Dig Dis Sci; 2012 Sep; 57(9):2334-9. PubMed ID: 22562538
[TBL] [Abstract][Full Text] [Related]
12. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.
Kleist B; Xu L; Li G; Kersten C
Int J Clin Exp Pathol; 2011 Apr; 4(4):327-35. PubMed ID: 21577318
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
Horst D; Kriegl L; Engel J; Kirchner T; Jung A
Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Lugli A; Iezzi G; Hostettler I; Muraro MG; Mele V; Tornillo L; Carafa V; Spagnoli G; Terracciano L; Zlobec I
Br J Cancer; 2010 Jul; 103(3):382-90. PubMed ID: 20606680
[TBL] [Abstract][Full Text] [Related]
15. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
Wu XS; Xi HQ; Chen L
World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
[TBL] [Abstract][Full Text] [Related]
16. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
17. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
[TBL] [Abstract][Full Text] [Related]
18. Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer.
Patel BB; Yu Y; Du J; Levi E; Phillip PA; Majumdar AP
Biochem Biophys Res Commun; 2009 Jan; 378(3):344-7. PubMed ID: 19010307
[TBL] [Abstract][Full Text] [Related]
19. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
